- ►diabetesjournals.org B Amann, R Tinzmann, B Angelkort - Diabetes Care, 2003 - Am Diabetes Assoc OBJECTIVE—Chemokines play an important role in the pathogenesis of diabetic
nephropathy. Angiotensin II induces several fibrogenic chemokines, namely
monocyte chemoattractant protein-1 (MCP-1) and transforming growth ... Cited by 71 - Related articles - BL Direct - All 5 versions
T Morii, H Fujita, T Narita, T Shimotomai, H … - Journal of diabetes and its complications, 2003 - Elsevier Monocyte chemoattractant protein-1 (MCP-1), is a chemokine that mediates renal
interstitial inflammation, tubular atrophy, and interstitial fibrosis by
recruiting monocytes/macrophages into renal tubulointerstitium. Recent ... Cited by 61 - Related articles - All 9 versions
T Wada, K Furuichi, N Sakai, Y Iwata, K … - Kidney international, 2000 - nature.com We examined whether locally expressed MCP-1 participates in human diabetic
nephropathy via recruiting and activating monocytes/macrophages (M ). Urinary
and serum MCP-1 levels were measured by enzyme-linked immunosorbent assay ... Cited by 150 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org T Wada, H Yokoyama, K Matsushima, K … - Nephrology Dialysis Transplantation, 2003 - ERA-EDTA Both metabolic and haemodynamic pathways impact on the progression of diabetic
nephropathy [1,2]. Chronic hyperglycaemia, advanced glycation end (AGE)
products, increase of sorbitol, activation of protein kinase C (PKC), ... Cited by 11 - Related articles - BL Direct - All 4 versions
FY Chow, DJ Nikolic-Paterson, E Ozols, RC … - Kidney international, 2006 - nature.com Diabetic nephropathy involves a renal inflammatory response induced by the
diabetic milieu. Macrophages accumulate in diabetic kidneys in association with
the local upregulation of monocyte chemoattractant protein-1 (MCP-1); ... Cited by 76 - Related articles - BL Direct - All 3 versions
S Kiyici, E Erturk, F Budak, C Ersoy, E Tuncel … - Archives of medical research, 2006 - Elsevier Monocyte chemoattractant protein (MCP)-1 is suggested to be implicated in the
pathogenesis of diabetic nephropathy by activating and recruiting monocytes to
the glomerulus via regulation of adhesion molecule expressions. The aim of ... Cited by 21 - Related articles - All 14 versions
- ►oxfordjournals.org S Hagiwara, Y Makita, L Gu, M Tanimoto, M … - Nephrology Dialysis Transplantation, 2006 - ERA-EDTA Background. Previous studies reported that eicosapentaenoic acid (EPA) was
effective against any renal diseases including diabetic nephropathy. Monocyte
chemoattractant protein-1 (MCP-1) is a regulating macrophage recruitment ... Cited by 23 - Related articles - BL Direct - All 5 versions
F Chow, E Ozols, DJ Nikolic-Paterson, RC … - Kidney international, 2004 - nature.com Macrophage-mediated renal injury has been implicated in progressive forms of
glomerulonephritis; however, a role for macrophages in type 2 diabetic
nephropathy, the major cause of end-stage renal failure, has not been ... Cited by 129 - Related articles - All 4 versions
- Free from Publisher F Chiarelli, F Cipollone, A Mohn, M Marini, A … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We studied 30 patients with type 1 diabetes (15
with and 15 without microalbuminuria) compared with matched healthy control
subjects. Plasma MCP-1 and plasma oxidant status (vitamin E, fluorescent ... Cited by 46 - Related articles - BL Direct - All 6 versions
- ►sjkdt.org S Ibrahim, L Rashed - Saudi Journal of Kidney Diseases and Transplantation, 2009 - sjkdt.org Diabetic nephropathy (DN) is the leading cause of end-stage renal disease in the
western world. Increased number of interstitial macrophages has been observed in
biopsies from patients with DN. Monocyte chemo-attractant protein-1 (MCP-1) ... Cited by 1 - Related articles - Cached - All 5 versions
